… For the transition period the IUPHAR Committee on Receptor Nomenclature and Drug
Classification, in keeping with the proposal by Abbracchio and Burnstock (1994), recommends …

There have been many advances in our knowledge about different aspects of P2Y receptor
signaling since the last review published by our International Union of Pharmacology …

There has been an exponential growth in interest n purinoceptors since the potent effects of
purines were first reported in 1929 and purinoceptors defined in 1978. A distinction between …

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial
publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key …

Purinergic receptors, represented by several families, are arguably the most abundant
receptors in living organisms and appeared early in evolution. After slow acceptance, purinergic …

The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial
publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 …

In this review, after a summary of the history and current status of the receptors involved in
purinergic signalling, we focus on the distribution and physiological roles of purines and …

… activation is now beginning to be elucidated, and expression of astrocytic mRNA in oocytes
suggests that at least two P2Y-purinoceptors, P2Y1 and P2Y2 (as designated by Abbracchio …

The cloning of a human G-protein-coupled receptor (GPCR) that specifically responds to
UDP-glucose and related sugar-nucleotides has been reported recently. This receptor has …

Nucleotides and cysteinyl‐leukotrienes (CysLTs) are unrelated signaling molecules inducing
multiple effects through separate G‐protein‐coupled receptors: the P2Y and the CysLT …